Biomedical Engineering Reference
In-Depth Information
80. Kennedy, G.C., Matsuzaki, H., Dong, S., Liu, W.M., Huang, J., et al.,
2003, “Large-scale genotyping of complex DNA,” Nat. Biotechnol., 21,
pp. 1233-1237.
81. Weissleder, R., and Pittet, M.J., 2008, “Imaging in the era of molecular
oncology,” Nature, 452, pp. 580-589.
82. Kraitchman, D.L., Heldman, A.W., Atalar, E., Amado, L.C., Martin, B.J., et
al., 2003, “In vivo magnetic resonance imaging of mesenchymal stem cells in
myocardial infarction,” Circulation, 107, pp. 2290-2293.
83. Nida, D.L., Rahman, M.S., Carslon, K.D., Richards-Kortum, R., Follen, M.,
2005, “Fluorescent nanocrystals for use in early cancer detection,” Gynecol.
Oncol., 99, pp. S89-S94.
84. Cross, S.E., Jin, Y.S., Rao, J., Gimzewski, J.K., 2007, “Nanomechanical
analysis of cells from cancer patients,” Nat. Nanotechnol., 2, pp. 780-783.
85. Gao, X., Cui, Y., Levenson, R.M., Chung, L.W., Nie, S., 2004, “In vivo cancer
targeting and imaging with semiconductor quantum dots,” Nat. Biotechnol.,
22, pp. 969-976.
86. Rapaport, N., Gao, Z., Kennedy, A., 2007, “Multifunctional nanoparticles
for combining ultrasonic tumor imaging and targeted chemotherapy,” J. Natl.
Cancer Inst., 99, pp. 1095-1106.
87. Tang, N., Du, G., Wang, N., Liu, C., Hang, H., Liang, W., 2007, “Improving
penetration in tumors with nanoassemblies of phospholipids and doxorubicin,”
J. Natl. Cancer Inst., 99, pp. 1004-1015.
88. Chakravarty, P., Marches, R., Zimmerman, N.S., Swafford, A.D., Bajaj, P.,
et al., 2008, “Thermal ablation of tumor cells with antibody-functionalized
single-walled carbon nanotubes,” Proc. Natl. Acad. Sci. U.S.A., 105,
pp. 8697-8702.
89. MacBeath, G., 2002, “Protein microarrays and proteonomics,” Nat. Genet., 32,
pp. 526-532.
90. Lesniak, M.S., Upadhyay, U., Goodwin, R., Tyler, B., Brem, H., 2005, “Local
delivery of doxorubicin for the treatment of malignant brain tumors in rats,”
Anticancer Res., 25, pp. 3825-3831.
91. Misra, A., Ganesh, S., Shahiwala, A., Shah, S.P., 2003, “Drug delivery
to the central nervous system: A review,” J. Pharm. Pharm. Sci., 6,
pp. 252-273.
92. Beduneau, A., Saulnier, P., Benoit, J.P., 2007, “Active targeting of brain tumors
using nanocarriers,” Biomaterials, 28, pp. 4947-4967.
93. Liu, Z., Cai, W., He, L., Nakayama, N., Chen, K., et al., 2007, “In vivo
biodistribution and highly efficient tumor targeting of carbon nanotubes in
mice,” Nat. Nano., 2, pp. 47-52.
94. Bangham, A.D., Standish, M.M., Watkins, J.C., “Diffusion of univalent
ions across the lamellae of swollen phospholipids,” J. Mol. Biol., 13, pp. 238-
252.
95. Heath, T.D., Fraley, R.T., Papahdjopoulos, D., 1980, “Antibody targeting of
liposomes: cell specificity obtained by conjugation of F(ab¢)2 to vesicle surface,”
Science, 210, pp. 539-541.
96. Duncan, R., 2006, “Polymer conjugates as anticancer nanomedicines,” Nat.
Rev. Cancer, 6, pp. 688-701.
